Application
This product is intended for use in the potency assay according to the Ph. Eur. monograph on Etanercept (2895).
General description
Etanercept is a tumor necrosis factor (TNF) antagonist that acts by binding with TNF cytokine or protein, thereby blocking its interaction with cell surface receptors. This dimeric fusion protein consists of 934 amino acids with a molecular mass of ~150KDa.This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
This product has met the following criteria to qualify for the following awards: